IL72188A - 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them - Google Patents

7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL72188A
IL72188A IL72188A IL7218884A IL72188A IL 72188 A IL72188 A IL 72188A IL 72188 A IL72188 A IL 72188A IL 7218884 A IL7218884 A IL 7218884A IL 72188 A IL72188 A IL 72188A
Authority
IL
Israel
Prior art keywords
tetrahydroimidazo
quinazolin
piperidino
salts
preparation
Prior art date
Application number
IL72188A
Other languages
English (en)
Other versions
IL72188A0 (en
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of IL72188A0 publication Critical patent/IL72188A0/xx
Publication of IL72188A publication Critical patent/IL72188A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
IL72188A 1983-06-21 1984-06-21 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them IL72188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58111498A JPS604186A (ja) 1983-06-21 1983-06-21 イミダゾキナゾリン化合物

Publications (2)

Publication Number Publication Date
IL72188A0 IL72188A0 (en) 1984-10-31
IL72188A true IL72188A (en) 1987-03-31

Family

ID=14562811

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72188A IL72188A (en) 1983-06-21 1984-06-21 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4596806A (xx)
EP (1) EP0129258B1 (xx)
JP (1) JPS604186A (xx)
KR (1) KR910003153B1 (xx)
AT (1) ATE29884T1 (xx)
AU (1) AU558124B2 (xx)
CA (1) CA1231946A (xx)
DE (1) DE3466392D1 (xx)
DK (1) DK162999C (xx)
ES (1) ES533609A0 (xx)
FI (1) FI77864C (xx)
GR (1) GR81629B (xx)
IE (1) IE57736B1 (xx)
IL (1) IL72188A (xx)
NO (1) NO161220C (xx)
PH (1) PH19413A (xx)
PT (1) PT78775A (xx)
YU (1) YU43576B (xx)
ZA (1) ZA844437B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
ZA851131B (en) * 1984-02-15 1986-09-24 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)oxyalkylamides
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4766126A (en) * 1986-01-10 1988-08-23 Daiichi Seiyaku Co., Ltd. Process for treatment of nephritis with imidazoquinazolines
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4761416A (en) * 1986-07-25 1988-08-02 Syntex (U.S.A.) Inc. N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Also Published As

Publication number Publication date
FI842532A (fi) 1984-12-22
EP0129258A1 (en) 1984-12-27
ES8603483A1 (es) 1985-12-16
ZA844437B (en) 1985-01-30
PT78775A (en) 1984-07-01
AU558124B2 (en) 1987-01-22
GR81629B (xx) 1984-12-11
EP0129258B1 (en) 1987-09-23
NO161220C (no) 1989-07-19
FI842532A0 (fi) 1984-06-21
NO161220B (no) 1989-04-10
JPS635030B2 (xx) 1988-02-01
KR850000442A (ko) 1985-02-27
IE57736B1 (en) 1993-03-24
IE841549L (en) 1984-12-21
FI77864B (fi) 1989-01-31
DE3466392D1 (de) 1987-10-29
YU43576B (en) 1989-08-31
CA1231946A (en) 1988-01-26
US4596806A (en) 1986-06-24
DK162999C (da) 1992-06-01
YU107884A (en) 1986-10-31
FI77864C (fi) 1989-05-10
NO842502L (no) 1984-12-27
DK290084A (da) 1984-12-22
DK162999B (da) 1992-01-06
PH19413A (en) 1986-04-10
ATE29884T1 (de) 1987-10-15
AU2943284A (en) 1985-01-03
ES533609A0 (es) 1985-12-16
KR910003153B1 (ko) 1991-05-20
JPS604186A (ja) 1985-01-10
DK290084D0 (da) 1984-06-13
IL72188A0 (en) 1984-10-31

Similar Documents

Publication Publication Date Title
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
EP0159708A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
AR242797A1 (es) Procedimiento para la preparacion de derivados de acido 16,17-acetal substituido pregnano-21-oico.
NO842514L (no) Fremgangsmaate for fremstilling av bicyklo(3,2,1)oktankarboksylsyre-derivater.
IT8421695A0 (it) Procedimento per la preparazione di 3, 11-dimetil-2-nonacosanone.
AU557580B2 (en) 15-cycloaliphatic derivatives of 13,14-didehydro- carboprostacyclins
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
NO862910D0 (no) Fremgangsmaate for fremstilling av 3,7-disubstituerte 3-cefem-forbindelser.
NO161856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,4-diamino-1,2,5-tiadiazol-derivater.
IT8424230A0 (it) Procedimento per la preparazione di 3,4,5-trimetossi-benzonitrile.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
IT8223632A0 (it) Procedimento per la preparazione di 2,2-dialchilamino-1-nitroeteni.
ES530165A0 (es) Procedimiento para la preparacion del fosfato del (+) 14, 15-dehidro-(3 , 16 )-eburnamenina-14-carboxilato de etilo
IT8424141A0 (it) Procedimento per la preparazione di 3,5-etano-2,4-dodecadienoati.
IT8920927A0 (it) Procedimenti per la preparazione di composti prostanoici ad attivita' antiaggregante piastrinica, antitrombotica, composizioni farmaceutiche che li contengono.
IT8420686A1 (it) "procedimenti per la preparazione di derivati del bis-idrossietilmercapto-1,10 - decano"/
FI845008A0 (fi) Anordning foer foerbindning av tvaettbaecken med avloppsroer.
IT8220219A0 (it) Procedimento per la preparazione di 2, 2-dialchilamino-1-nitroeteni.
ES539138A0 (es) Procedimiento de preparacion de derivados de la 1,4-dihidroquinoleina
AR226096A1 (es) Procedimiento para la preparacion de n,n-dimetil-10-(1-aza(2,2,2)-biciclo-3-octil)10h-2-fenotiazinsulfonamida
ES518050A0 (es) Procedimiento de preparacion de 3,7-dihidro-1h-purinas-2,6-diona sustituidas.